<DOC>
	<DOCNO>NCT00513201</DOCNO>
	<brief_summary>OBJECTIVE : To compare lispro insulin regular insulin glycemic control patient liver cirrhosis type 2 diabetes subject . METHODS : 108 patient liver cirrhosis type 2 diabetes randomly treat regular insulin lispro . After 122 week cross-over carry patient followed-up 122 week . Then , patient receive standard breakfast 145 kcal follow 12 U.I . regular insulin lispro , C-peptide insulin serum level determine 300 minute .</brief_summary>
	<brief_title>Lyspro Insulin vs Regular Insulin Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Insulintreated diabetes mellitus liver cirrhosis Oral hypoglycemic agent treat diabetes mellitus Liver cancer</criteria>
	<gender>All</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>lyspro</keyword>
	<keyword>regular insulin</keyword>
	<keyword>cirrhotic patient</keyword>
</DOC>